Literature DB >> 1654883

Characterization of the tyrosine phosphorylation of calpactin I (annexin II) induced by platelet-derived growth factor.

R Brambilla1, R Zippel, E Sturani, L Morello, A Peres, L Alberghina.   

Abstract

Stimulation in vivo of Swiss 3T3 fibroblasts with platelet-derived growth factor (PDGF) in the presence of orthovanadate induces the tyrosine phosphorylation of a 39 kDa protein, identified as the phosphorylated slow-migrating form of calpactin I (annexin II) heavy chain, p36. In fact, in PDGF-stimulated cells, anti-(calpactin I) antibodies recognize a doublet of bands, p36 and p39, and the latter disappears upon treatment with phosphatase. In many regards phosphorylation of p39 differs from the rapid and transient phosphorylation of the PDGF receptor and of other substrates: (a) it has slower kinetics but is then stable for longer periods of time; (b) it occurs at 37 degrees C but not at 4 degrees C; and (c) whereas most of the tyrosine-phosphorylated proteins are associated with membrane-enriched preparations, membrane association of p39 only occurs in the presence of Ca2+. Moreover, calpactin I leaks out of permeabilized cells at 0.1 microM free Ca2+, whereas it remains associated with the cells at concentrations of Ca2+ greater than or equal to 1 microM. PDGF does not stimulate phosphoinositide turnover (and thus Ca2+ mobilization) at 4 degrees C; thus it can be suggested that the Ca(2+)-dependent translocation of the protein to membrane/cytoskeletal structures is a necessary condition for its phosphorylation. In addition, calpactin I may not be a direct substrate for the PDGF receptor kinase, but rather the substrate of another tyrosine kinase activated by the receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654883      PMCID: PMC1151364          DOI: 10.1042/bj2780447

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src.

Authors:  J A Cooper; C S King
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

Review 2.  Platelet-derived growth factor: mechanism of action and possible in vivo function.

Authors:  C H Heldin; B Westermark
Journal:  Cell Regul       Date:  1990-07

3.  Regulation of calpactin I phospholipid binding by calpactin I light-chain binding and phosphorylation by p60v-src.

Authors:  M A Powell; J R Glenney
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

4.  Platelet-derived growth factor induces multisite phosphorylation of pp60c-src and increases its protein-tyrosine kinase activity.

Authors:  K L Gould; T Hunter
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

5.  The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo.

Authors:  K L Gould; J R Woodgett; C M Isacke; T Hunter
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

6.  Further evidence for a phospholipase C-coupled G protein in hamster fibroblasts. Induction of inositol phosphate formation by fluoroaluminate and vanadate and inhibition by pertussis toxin.

Authors:  S Paris; J Pouysségur
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

7.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

8.  Properties of the voltage-dependent calcium channel of mouse Swiss 3T3 fibroblasts.

Authors:  A Peres; E Sturani; R Zippel
Journal:  J Physiol       Date:  1988-07       Impact factor: 5.182

9.  Epidermal-growth-factor-stimulated phosphorylation of calpactin II in membrane vesicles shed from cultured A-431 cells.

Authors:  J Blay; K A Valentine-Braun; J K Northup; M D Hollenberg
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

10.  Rat mast cells permeabilised with streptolysin O secrete histamine in response to Ca2+ at concentrations buffered in the micromolar range.

Authors:  T W Howell; B D Gomperts
Journal:  Biochim Biophys Acta       Date:  1987-02-18
View more
  5 in total

Review 1.  Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.

Authors:  Pomila Singh
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

Review 2.  Annexin II tetramer: structure and function.

Authors:  D M Waisman
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

3.  Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/sphingolipid pathway.

Authors:  Christel Cinq-Frais; Christelle Coatrieux; Aude Savary; Romina D'Angelo; Corinne Bernis; Robert Salvayre; Anne Nègre-Salvayre; Nathalie Augé
Journal:  Redox Biol       Date:  2014-12-16       Impact factor: 11.799

Review 4.  Annexin A2 and Kidney Diseases.

Authors:  Ling Lin; Kebin Hu
Journal:  Front Cell Dev Biol       Date:  2022-09-02

5.  Three are better than one: plasminogen receptors as cancer theranostic targets.

Authors:  Patrizia Ceruti; Moitza Principe; Michela Capello; Paola Cappello; Francesco Novelli
Journal:  Exp Hematol Oncol       Date:  2013-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.